These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26109072)

  • 1. A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium.
    Kodali S; Vinogradov E; Lin F; Khoury N; Hao L; Pavliak V; Jones CH; Laverde D; Huebner J; Jansen KU; Anderson AS; Donald RG
    J Biol Chem; 2015 Aug; 290(32):19512-26. PubMed ID: 26109072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage.
    Romero-Saavedra F; Laverde D; Kalfopoulou E; Martini C; Torelli R; Martinez-Matamoros D; Sanguinetti M; Huebner J
    J Infect Dis; 2019 Oct; 220(10):1589-1598. PubMed ID: 31289829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and characterization of bacterial polysaccharides in drug-resistant enterococci.
    Ali L; Blum HE; Sakιnç T
    Glycoconj J; 2019 Oct; 36(5):429-438. PubMed ID: 31230165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.
    Laverde D; Wobser D; Romero-Saavedra F; Hogendorf W; van der Marel G; Berthold M; Kropec A; Codee J; Huebner J
    PLoS One; 2014; 9(10):e110953. PubMed ID: 25333799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SagA as a novel vaccine target for the prevention of Enterococcus faecium infections.
    Kropec A; Sava IG; Vonend C; Sakinc T; Grohmann E; Huebner J
    Microbiology (Reading); 2011 Dec; 157(Pt 12):3429-3434. PubMed ID: 21903755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections.
    Romero-Saavedra F; Laverde D; Budin-Verneuil A; Muller C; Bernay B; Benachour A; Hartke A; Huebner J
    PLoS One; 2015; 10(8):e0136625. PubMed ID: 26322633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of cross-opsonic effect leads to the discovery of PPIase-domain containing protein vaccine candidate to prevent infections by Gram-positive ESKAPE pathogens.
    Sadones O; Kramarska E; Laverde D; Berisio R; Huebner J; Romero-Saavedra F
    BMC Microbiol; 2024 Jul; 24(1):280. PubMed ID: 39068414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid.
    Theilacker C; Kaczynski Z; Kropec A; Fabretti F; Sange T; Holst O; Huebner J
    Infect Immun; 2006 Oct; 74(10):5703-12. PubMed ID: 16988246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.
    Huebner J; Wang Y; Krueger WA; Madoff LC; Martirosian G; Boisot S; Goldmann DA; Kasper DL; Tzianabos AO; Pier GB
    Infect Immun; 1999 Mar; 67(3):1213-9. PubMed ID: 10024563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterococcal surface protein contributes to persistence in the host but is not a target of opsonic and protective antibodies in Enterococcus faecium infection.
    Sava IG; Heikens E; Kropec A; Theilacker C; Willems R; Huebner J
    J Med Microbiol; 2010 Sep; 59(Pt 9):1001-1004. PubMed ID: 20522627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serodiversity of opsonic antibodies against Enterococcus faecalis--glycans of the cell wall revisited.
    Theilacker C; Kaczyński Z; Kropec A; Sava I; Ye L; Bychowska A; Holst O; Huebner J
    PLoS One; 2011 Mar; 6(3):e17839. PubMed ID: 21437253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a capsular polysaccharide from Enterococcus faecium U0317 using a targeted approach to discover immunogenic carbohydrates for vaccine development.
    Laverde D; Armiento S; Molinaro A; Huebner J; De Castro C; Romero-Saavedra F
    Carbohydr Polym; 2024 Apr; 330():121731. PubMed ID: 38368077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium.
    Rakita RM; Quan VC; Jacques-Palaz K; Singh KV; Arduino RC; Mee M; Murray BE
    FEMS Immunol Med Microbiol; 2000 Aug; 28(4):291-9. PubMed ID: 10891652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci.
    Kalfopoulou E; Laverde D; Miklic K; Romero-Saavedra F; Malic S; Carboni F; Adamo R; Lenac Rovis T; Jonjic S; Huebner J
    Infect Immun; 2019 Sep; 87(9):. PubMed ID: 31285252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.
    Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J
    J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the development of immunotherapy regimens against enterococcal infections.
    Theilacker C; Krueger WA; Kropec A; Huebner J
    Vaccine; 2004 Dec; 22 Suppl 1():S31-8. PubMed ID: 15576199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.
    Cox AD; St Michael F; Aubry A; Cairns CM; Strong PC; Hayes AC; Logan SM
    Glycoconj J; 2013 Dec; 30(9):843-55. PubMed ID: 23974722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of peptidoglycan-associated proteins as vaccine candidates for enterococcal infections.
    Romero-Saavedra F; Laverde D; Wobser D; Michaux C; Budin-Verneuil A; Bernay B; Benachour A; Hartke A; Huebner J
    PLoS One; 2014; 9(11):e111880. PubMed ID: 25369230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.
    Wang Y; Huebner J; Tzianabos AO; Martirosian G; Kasper DL; Pier GB
    Carbohydr Res; 1999 Mar; 316(1-4):155-60. PubMed ID: 10420594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with the basic membrane protein (BMP) family ABC transporter elicits protection against Enterococcus faecium in a murine infection model.
    Yousief SW; Bahey-El-Din M; Zaghloul TI
    Microbes Infect; 2020 Apr; 22(3):127-136. PubMed ID: 31585177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.